Abiopharma

🔍 Rummler Wendy A (Executive)

Company: CREDIT ACCEPTANCE CORP (CACC)

Report Date: 2026-05-06

Detailed Transactions and Holdings:

• Acquired 2,068 shares of Common Stock at $333.94 per share (Direct)
  Date: 2026-05-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 21,615.10 | transaction_form_type: 4
• Sold 1,625 shares of Common Stock at $550.33 per share (Direct)
  Date: 2026-05-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 19,990.10 | transaction_form_type: 4 | Footnotes: F1
• Sold 126 shares of Common Stock at $551.14 per share (Direct)
  Date: 2026-05-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 19,864.10 | transaction_form_type: 4 | Footnotes: F2
• Sold 88 shares of Common Stock at $553.12 per share (Direct)
  Date: 2026-05-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 19,776.10 | transaction_form_type: 4 | Footnotes: F3
• Sold 177 shares of Common Stock at $553.79 per share (Direct)
  Date: 2026-05-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 19,599.10 | transaction_form_type: 4 | Footnotes: F4
• Sold 17 shares of Common Stock at $555.0 per share (Direct)
  Date: 2026-05-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 19,582.10 | transaction_form_type: 4
• Sold 19 shares of Common Stock at $557.08 per share (Direct)
  Date: 2026-05-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 19,563.10 | transaction_form_type: 4
• Sold 4 shares of Common Stock at $559.37 per share (Direct)
  Date: 2026-05-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 19,559.10 | transaction_form_type: 4
• Sold 12 shares of Common Stock at $565.15 per share (Direct)
  Date: 2026-05-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 19,547.10 | transaction_form_type: 4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-06 | Code: H | nature_of_ownership: By trust. | shares_owned_after: 2,704.00 | Footnotes: F5
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-06 | Code: H | nature_of_ownership: By trust. | shares_owned_after: 2,365.50 | Footnotes: F6
• Sold 2,068 shares of Employee Stock Option (right to buy) at $333.94 per share (Derivative)
  Date: 2026-05-06 | Code: M | Expires: 2026-12-30 | Exercise: 2024-12-30 | equity_swap_involved: 0 | shares_owned_after: 1,994.00 | transaction_form_type: 4
• Holds 1,250 shares of Employee Stock Option (right to buy) at $390.39 per share (Derivative)
  Date: 2026-05-06 | Code: H | Expires: 2027-04-28 | Exercise: 2025-04-28 | shares_owned_after: 1,250.00
• Holds 10,000 shares of Employee Stock Option (right to buy) at $468.67 per share (Derivative)
  Date: 2026-05-06 | Code: H | Expires: 2028-10-06 | shares_owned_after: 10,000.00 | Footnotes: F7

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $550.00 to $550.90, inclusive. The reporting person undertakes to provide to Credit Acceptance Corporation, any security holder of Credit Acceptance Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $551.03 to $551.40, inclusive.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $552.53 to $553.40, inclusive.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $553.53 to $554.43, inclusive.
• F5: These shares are owned of record by Kevin Rummler, spouse of Wendy A. Rummler, as trustee of the Kevin Rummler Revocable Trust.
• F6: These shares are owned of record by Wendy A. Rummler, as trustee of the Wendy A. Rummler Revocable Trust.
• F7: The option, initially representing the right to purchase 10,000 shares, is exercisable in four equal annual installments beginning on October 6, 2023, which was the first anniversary of the date on which the option was granted.